Re: Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy

Aditya Bagrodia; Yair Lotan

doi:10.1016/j.eururo.2017.06.017

Re: Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy

Aditya Bagrodia, Yair Lotan

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	European Urology
DOIs	https://doi.org/10.1016/j.eururo.2017.06.017
State	Accepted/In press - 2017

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2017.06.017

Cite this

@article{9e64a0fc56e54994a60e9791171f86bc,

title = "Re: Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy",

author = "Aditya Bagrodia and Yair Lotan",

year = "2017",

doi = "10.1016/j.eururo.2017.06.017",

language = "English (US)",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

}

TY - JOUR

T1 - Re

T2 - Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy

AU - Bagrodia, Aditya

AU - Lotan, Yair

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?scp=85021225579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021225579&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2017.06.017

DO - 10.1016/j.eururo.2017.06.017

M3 - Article

C2 - 28655542

AN - SCOPUS:85021225579

SN - 0302-2838

JO - European Urology

JF - European Urology

ER -

Re: Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this